Pluristem Therapeutics Inc. news

   Watch this stock
Showing stories 1 - 10 of about 85   

Articles published

PSTI 1.58 +0.01 (0.64%)
price chart
Pluristem Therapeutics, Inc. (NASDAQ:PSTI): Company Rating and Earnings Roundup
Investors will be watching to see if the company hits or misses on earnings expectations after the next release. Pluristem Therapeutics, Inc. (NASDAQ:PSTI) is slated to next post quarterly results on or around 2016-09-08. The company most recently ...
Strong Sell Calls Count For Pluristem Therapeutics, Inc. (NASDAQ:PSTI) At 0
Buy calls count on Pluristem Therapeutics, Inc. (NASDAQ:PSTI) stock stands at 0 and Sell recommendations is 0 while hold recommendations is 0. Pluristem Therapeutics, Inc. (NASDAQ:PSTI) has a total of 2 Strong Buy calls and 0 Strong Sell advises as of ...
Pluristem Therapeutics (PSTI) Enters into Licensing Agreement with TES Holdings Co
Pluristem Therapeutics Inc. (Nasdaq: PSTI) today announced that it has entered into a licensing agreement with TES Holdings Co.
Pluristem Therapeutics Signs Licensing Deal with TES Holdings for Placental ...  Sonoran Weekly Review
Pluristem Therapeutics, Inc. (PSTI) Broker Price Targets For The Coming Week
Market analysts have recently updated their ratings and price targets on shares of Pluristem Therapeutics, Inc. (PSTI).
Pluristem Therapeutics, Inc. (NASDAQ:PSTI) Costs Of Goods Sold Stands At $0 ...
For the fiscal ended 2015-06-30, Pluristem Therapeutics, Inc. (NASDAQ:PSTI) comprehensive income was $2.14 millions and for the quarter ended 2015-06-30, it was $2.14 millions.
Pluristem Therapeutics, Inc. (PSTI) Latest Broker Views
A number of investment brokers have recently updated their price targets on shares of Pluristem Therapeutics, Inc. (PSTI).
Pluristem Therapeutics, Inc. (NASDAQ:PSTI) Closes At $1.58  Vanguard Tribune
Pluristem Therapeutics, Inc. (PSTI) Updated Broker Price Targets  Share Trading News
Pluristem Therapeutics, Inc. (NASDAQ:PSTI) Basic Consolidated EPS At $-0.3511
The yearly basic consolidated EPS for Pluristem Therapeutics, Inc. (NASDAQ:PSTI) for the period ended 2015-06-30 was $-0.3511.
Pluristem Therapeutics Inc.: Pluristem Reports Third Quarter Fiscal 2016 ...  The Wall Street Transcript
Pluristem Therapeutics Inc. (PSTI) Sees Large Increase in Short Interest
Pluristem Therapeutics logo Pluristem Therapeutics Inc. (NASDAQ:PSTI) was the target of a large increase in short interest during the month of March.
Pluristem Therapeutics, Inc. (PSTI) Latest Broker Coverage
A number of investment brokers have recently updated their price targets on shares of Pluristem Therapeutics, Inc. (PSTI).
After Last Week What Do Analysts Think Of Pluristem Therapeutics, Inc. (PSTI)  Share Trading News
Pluristem Therapeutics Inc. Pipeline Review, Industry Analysis, Market Size ...
market-research-store1218 “Pluristem Therapeutics Inc. Global 2016 Clinical Trials Review, H2” provides an detailed overview of Pluristem Therapeutics Inc. scenario. Report includes top line data relating on Pluristem Therapeutics Inc. Global clinical ...